Published within
| Type |
Product title / description
|
Pub
|
Price |
Company Profile
|
Nycomed International Management (Nycomed), a Takeda company, is engaged in the development and marketing of branded medicines primarily in the areas of gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. The company has operations in 50 countries worldwide. It primarily operates in Europe, the US, Latin America, South Africa, Canada and Russia. The company is headquartered in Zurich, Switzerland and employed 12,506 people as of December 31, 2010.
Published By MarketLine
|
20 Dec 2011 |
$175
|
Company Profile
|
Alcon, Inc. (Alcon or 'the company'), a business division of Novartis, is a global medical specialty company focused on eye care. It is engaged in the development, manufacture and marketing of pharmaceuticals, surgical equipment and devices, and consumer eye care products for the treatment of eye disorders. Alcon markets its products across 180 countries and operates in over 75 countries. The company primarily operates in the US, Japan and Switzerland. It is headquartered in Hunenberg, Switzerland and employed...
Published By MarketLine
|
28 Jun 2012 |
$175
|
Company Profile
|
Galenica (or 'the group') is engaged in the development, manufacture and marketing of pharmaceutical products. It also operates pharmacies, and provides logistical and database services. The group has its presence in Europe, America and other countries. It is headquartered in Berne, Switzerland and employed 5,926 people as on December 31, 2011.
Published By MarketLine
|
17 Jul 2012 |
$175
|
Company Profile
|
F. Hoffmann-La Roche Ltd (Roche or 'the group') is one of the leading research-focused healthcare groups in the world. It is engaged in the discovery, development and commercialization of innovative diagnostic and therapeutic products. Roche is headquartered in Basel, Switzerland, and employed 80,129 people as of December 31, 2011.
Published By MarketLine
|
20 Jul 2012 |
$175
|
Company Profile
|
Novartis AG (Novartis or 'the company') is one of the Big Pharma companies having strong presence in diverse biopharmaceutical segments. It is engaged in the research, development, manufacture and marketing of branded drugs, generic pharmaceutical products, preventive vaccines, diagnostic tools and consumer health products. The company operates in more than 140 countries across the globe. It is headquartered in Basel, Switzerland, and employed 123,686 people as of December 31, 2011.
Published By MarketLine
|
28 Sep 2012 |
$175
|
Company Profile
|
Lonza Group (Lonza or 'the group') is a leading global provider of products and services to the pharmaceutical, chemical and life science industries. The group operates in Europe, North America, Latin America, Asia and other regions. Lonza is headquartered in Basel, Switzerland and employed 11,001 people as of December 31, 2011.
Published By MarketLine
|
25 Oct 2012 |
$175
|
Company Profile
|
Actelion (or 'the company') is a biopharmaceutical company focused on the discovery, development and commercialization of synthetic small-molecule drugs to address high unmet medical needs. It has affiliates in more than 30 countries including the US, Canada, Brazil, Australia, Japan and Switzerland, which provide distribution, sales and marketing services. Actelion has operations in the Americas, Europe and Asia-Pacific. The company is headquartered in Allschwil, Switzerland and employed 2,570 people as
Published By MarketLine
|
30 Oct 2012 |
$175
|
Company Profile
|
Octapharma (or 'the group') is engaged in the research and development of human proteins for various therapeutic areas. It provides products for the treatment of coagulation disorders and immune diseases, and also offers intensive care and emergency medicines. The group operates in Europe, North and South Americas, Asia Pacific and the Middle East. It is headquartered in Lachen, Switzerland, and employed 4,514 people as of December 31, 2011.
Published By MarketLine
|
27 Nov 2012 |
$175
|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.